Larimar Therapeutics, Inc. - Common Stock, par value $0.01 per share (LRMR)

CUSIP: 517125100

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / Common Stock, par value $0.01 per share
Shares outstanding
103,654,385
Total 13F shares
14,391,311
Share change
-835,377
Total reported value
$28,222,000
Price per share
$1.96
Number of holders
34
Value change
-$2,241,518
Number of buys
4
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 517125100?
CUSIP 517125100 identifies LRMR - Larimar Therapeutics, Inc. - Common Stock, par value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Larimar Therapeutics, Inc. - Common Stock, par value $0.01 per share (LRMR) as of Q2 2022

As of 30 Jun 2022, Larimar Therapeutics, Inc. - Common Stock, par value $0.01 per share (LRMR) was held by 34 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,391,311 shares. The largest 10 holders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), CHI Advisors LLC, RA CAPITAL MANAGEMENT, L.P., Opaleye Management Inc., MANGROVE PARTNERS, JANUS HENDERSON GROUP PLC, MORGAN STANLEY, VANGUARD GROUP INC, Verition Fund Management LLC, and Atlas Venture Advisors, Inc.. This page lists 34 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.